These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33568248)

  • 1. The neural substrates of risky rewards and losses in healthy volunteers and patient groups: a PET imaging study.
    Skandali N; Majuri J; Joutsa J; Baek K; Arponen E; Forsback S; Kaasinen V; Voon V
    Psychol Med; 2022 Oct; 52(14):3280-3288. PubMed ID: 33568248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurochemical substrates of habitual and goal-directed control.
    Voon V; Joutsa J; Majuri J; Baek K; Nord CL; Arponen E; Forsback S; Kaasinen V
    Transl Psychiatry; 2020 Mar; 10(1):84. PubMed ID: 32127520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.
    Majuri J; Joutsa J; Johansson J; Voon V; Alakurtti K; Parkkola R; Lahti T; Alho H; Hirvonen J; Arponen E; Forsback S; Kaasinen V
    Neuropsychopharmacology; 2017 Apr; 42(5):1169-1177. PubMed ID: 27882998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET study.
    Majuri J; Joutsa J; Arponen E; Forsback S; Kaasinen V
    Neuroimage; 2018 Dec; 183():1-6. PubMed ID: 30077742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [
    Majuri J; Joutsa J; Johansson J; Voon V; Parkkola R; Alho H; Arponen E; Kaasinen V
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1281-1288. PubMed ID: 29032922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal frontostriatal connectivity and serotonin function in gambling disorder: A preliminary exploratory study.
    Bellmunt-Gil A; Majuri J; Arponen E; Kaasinen V; Joutsa J
    J Behav Addict; 2023 Oct; 12(3):670-681. PubMed ID: 37561637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults.
    Oswald LM; Wand GS; Wong DF; Brown CH; Kuwabara H; Brašić JR
    Neuroimage; 2015 Jun; 113():26-36. PubMed ID: 25795343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 2A receptors contribute to the regulation of risk-averse decisions.
    Macoveanu J; Rowe JB; Hornboll B; Elliott R; Paulson OB; Knudsen GM; Siebner HR
    Neuroimage; 2013 Dec; 83():35-44. PubMed ID: 23810974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal presynaptic dopaminergic dysfunction in gambling disorder: A
    Pettorruso M; Martinotti G; Cocciolillo F; De Risio L; Cinquino A; Di Nicola M; Camardese G; Migliara G; Moccia L; Conte E; Janiri L; Di Giuda D
    Addict Biol; 2019 Sep; 24(5):1077-1086. PubMed ID: 30226290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Striatal Dopamine Synthesis Capacity in Gambling Addiction.
    van Holst RJ; Sescousse G; Janssen LK; Janssen M; Berry AS; Jagust WJ; Cools R
    Biol Psychiatry; 2018 Jun; 83(12):1036-1043. PubMed ID: 28728675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bias towards natural rewards away from gambling cues in gamblers undergoing active treatment.
    Schmidt C; Gleesborg C; Schmidt H; Kvamme TL; Lund TE; Voon V; Møller A
    Brain Res; 2021 Aug; 1764():147479. PubMed ID: 33852890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
    Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
    Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.
    Siessmeier T; Kienast T; Wrase J; Larsen JL; Braus DF; Smolka MN; Buchholz HG; Schreckenberger M; Rösch F; Cumming P; Mann K; Bartenstein P; Heinz A
    Eur J Neurosci; 2006 Jul; 24(1):305-13. PubMed ID: 16882026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dopaminergic and serotonergic transmission in the processing of primary and monetary reward.
    Schmidt C; Skandali N; Gleesborg C; Kvamme TL; Schmidt H; Frisch K; Møller A; Voon V
    Neuropsychopharmacology; 2020 Aug; 45(9):1490-1497. PubMed ID: 32392573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
    Frick A; Åhs F; Engman J; Jonasson M; Alaie I; Björkstrand J; Frans Ö; Faria V; Linnman C; Appel L; Wahlstedt K; Lubberink M; Fredrikson M; Furmark T
    JAMA Psychiatry; 2015 Aug; 72(8):794-802. PubMed ID: 26083190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic function and intertemporal choice.
    Joutsa J; Voon V; Johansson J; Niemelä S; Bergman J; Kaasinen V
    Transl Psychiatry; 2015 Jan; 5(1):e491. PubMed ID: 25562841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging in Parkinson's disease: the role of monoamines in behavior.
    Brooks DJ; Piccini P
    Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjects.
    Madsen K; Erritzoe D; Mortensen EL; Gade A; Madsen J; Baaré W; Knudsen GM; Hasselbalch SG
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):573-81. PubMed ID: 20623110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.